Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
In 2024, there were 8.4 million prescriptions and $8.6 billion in spending on GLP-1s in Medicaid, and 21.8 million claims and $27.5 billion in gross spending (not excluding rebates) on GLP-1s in Medicare (Figure 1)
Casper finds that some people have misconceptions especially older adults
What this means practically for media and the clinics: we can discuss the regulatory landscape, the research context, and what is happening globally
.png)
Food and Drug Administration (FDA) - "Saxenda (Liraglutide) Injection, for Subcutaneous Use." Accessed on April 3, 2024, at FDA - "Drug Compounding and Drug Shortages." Accessed on April 3, 2024, at Harvard T.H
US$ 21.09
US$ 28.63
US$ 21.65
US$ 24.78
US$ 27.45
US$ 27.94
US$ 25.13
